MMMichael T. Mullen

Michael T. Mullen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael T. Mullen has a total of 121 co-authors. Here are the top co-authors by number of shared publications:

  • Brendan G. Carr

    From the Department of Neurology (M.T.M., S.R.M., J.J.), Leonard Davis Institute of Health Economics (M.T.M., W.P., G.D.), Department of Healthcare Management, Wharton School (W.P., G.D.), Department of Emergency Medicine (C.C.M.), University of Pennsylvania, Philadelphia; Philadelphia Fire Department, PA (C.C.M.); Department of Emergency Medicine, Massachusetts General Hospital, Boston (M.A.); and Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA (B.G.C., R.B.).

    9 shared publications
  • Steven R. Messé

    Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States

    8 shared publications
  • Scott E. Kasner

    Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States

    6 shared publications
  • Karen C. Albright

    National Telestroke Program, Department of Veteran Affairs, Washington, DC

    5 shared publications
  • Charles C. Branas

    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States

    4 shared publications
  • Lauren Hachmann Sansing

    Yale University School of Medicine

    4 shared publications

Latest Publications

  • Open Access

    Early Inflammatory Cytokine Expression in Cerebrospinal Fluid of Patients with Spontaneous Intraventricular Hemorrhage

    by Wendy C. Ziai, Adrian R. Parry-Jones, Carol B. Thompson, Lauren H. Sansing, Michael T. Mullen, Santosh B. Murthy, Andrew Mould, Saman Nekoovaght-Tak, Daniel F. Hanley

    We investigated cerebrospinal fluid (CSF) expression of inflammatory cytokines and their relationship with spontaneous intracerebral and intraventricular hemorrhage (ICH, IVH) and perihematomal edema (PHE) volumes in patients with acute IVH. Twenty-eight adults with IVH requiring external ventricular drainage for obstructive hydrocephalus had cerebrospinal fluid (CSF) collected for up to 10 days and had levels of interleukin-1α (IL-1α), IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor-α (TNFα), and C-C motif chemokine ligand CCL2 measured using enzyme-linked immunosorbent assay. Median [IQR] ICH and IVH volumes at baseline (T0) were 19.8 [5.8–48.8] and 14.3 [5.3–38] mL respectively. Mean levels of IL-1β, IL-6, IL-10, TNF-α, and CCL2 peaked early compared to day 9–10 (p < 0.05) and decreased across subsequent time periods. Levels of IL-1β, IL-6, IL-8, IL-10, and CCL2 had positive correlations with IVH volume at days 3–8 whereas positive correlations with ICH volume occurred earlier at day 1–2. Significant correlations were found with PHE volume for IL-6, IL-10 and CCL2 at day 1–2 and with relative PHE at days 7–8 or 9–10 for IL-1β, IL-6, IL-8, and IL-10. Time trends of CSF cytokines support experimental data suggesting association of cerebral inflammatory responses with ICH/IVH severity. Pro-inflammatory markers are potential targets for injury reduction.


  • Open Access

    Association Between Anxiety, Depression, and Post-traumatic Stress Disorder and Outcomes After Ischemic Stroke

    by Laura A. Stein, Emily Goldmann, Ahmad Zamzam, Jean M. Luciano, Steven R. Messé, Brett L. Cucchiara, Scott E. Kasner, Michael T. Mullen

    Background: Stroke patients are known to be at risk of developing anxiety, depression, and post-traumatic stress disorder (PTSD). Objective: To determine the overlap between anxiety, depression, and PTSD in patients after stroke and to determine the association between these disorders and quality of life, functional status, healthcare utilization, and return to work. Methods: A cross-sectional telephone survey was conducted to assess for depression, anxiety, PTSD, and health-related outcomes 6–12 months after first ischemic stroke in patients without prior psychiatric disease at a single stroke center. Results: Of 352 eligible subjects, 55 (16%) completed surveys. Seven subjects (13%) met criteria for probable anxiety, 6 (11%) for PTSD, and 11 for depression (20%). Of the 13 subjects (24%) who met criteria for any of these disorders, 6 (46%) met criteria for more than one, and 5 (39%) met criteria for all three. There were no significant differences in baseline characteristics, including stroke severity or neurologic symptoms, between those with or without any of these disorders. Those who had any of these disorders were less likely to be independent in their activities of daily living (ADLs) (54 vs. 95%, p < 0.001) and reported significantly worse quality of life (score of 0–100, median score of 50 vs. 80, p < 0.001) compared to those with none of these disorders. Conclusions: Anxiety, depression, and PTSD are common after stroke, have a high degree of co-occurrence, and are associated with worse outcomes, including quality of life and functional status.


  • Geographic Modeling to Quantify the Impact of Primary and Comprehensive Stroke Center Destination Policies

    by Michael T. Mullen, William Pajerowski, Steven R. Messé, C. Crawford Mechem, Judy Jia, Michael Abboud, Guy David, Brendan G. Carr, Roger Band

    Background and Purpose—: We evaluated the impact of a primary stroke center (PSC) destination policy in a major metropolitan city and used geographic modeling to evaluate expected changes for a comprehensive stroke center policy. Methods—: We identified suspected stroke emergency medical services encounters from 1/1/2004 to 12/31/2013 in Philadelphia, PA. Transport times were compared before and after initiation of a PSC destination policy on 10/3/2011. Geographic modeling estimated the impact of bypassing the closest hospital for the closest PSC and for the closest comprehensive stroke center. Results—: There were 2 326 943 emergency medical services runs during the study period, of which 15 099 had a provider diagnosis of stroke. Bypassing the closest hospital for a PSC was common before the official policy and increased steadily over time. Geographic modeling suggested that bypassing the closest hospital in favor of the closest PSC adds a median of 3.1 minutes to transport time. Bypassing to the closest comprehensive stroke center would add a median of 8.3 minutes. Conclusions—: Within a large metropolitan area, the time cost of routing patients preferentially to PSCs and comprehensive stroke centers is low.


  • Abstract TMP87: Non-Invasive Respiratory Impedance Enhances Cerebral Perfusion in Acute Stroke Patients

    by Christopher G Favilla, Rodrigo M Forti, Ahmad Zamzam, John A Detre, Michael T Mullen, Arjun G Yodh, Scott E Kasner, David R Busch, Wesley B Baker, Steven R Messe

    Introduction: Optimization of cerebral blood flow is a cornerstone of clinical management in a number of neurologic diseases, most notably acute ischemic stroke. Intra-thoracic pressure influences cardiac output and has the potential to impact cerebral blood flow (CBF). We aimed to quantify cerebral hemodynamic changes in acute ischemic stroke patients during increased respiratory impedance using a non-invasive oral device. Methods: Cerebral perfusion was measured during low (6cm H 2 0) and high (12cm H 2 0) levels of respiratory impedance in 20 patients within 72 hours of acute ischemic stroke. Microvascular CBF was measured by optical diffuse correlation spectroscopy, and middle cerebral artery mean flow velocity (MFV) was assessed by transcranial Doppler ultrasound. Results: High level respiratory impedance resulted in a 10% increase in MFV. Low level respiratory impedance resulted in a smaller (4%) non-significant change in MFV. Changes in cortical CBF were non-significant (figure). MFV varied across all studied levels (baseline vs low vs high, p=0.0017) with a significant test of trend (p=0.001), but this was not seen with microvascular CBF (p=0.33). Heart rate, cardiac output, and end tidal CO 2 remained stable during all levels of respiratory impedance. There was a small increase in mean arterial blood pressure at the low and high level of respiratory impedance, 4% (p=0.013) and 6% (p=0.017) respectively. All patients completed the protocol in its entirety, and the respiratory impedance exercise was well tolerated. Conclusions: Manipulating intrathoracic pressure via non-invasive respiratory impedance was safe and produced a small but measurable increase in cerebral blood flow in acute stroke patients. Future studies are warranted to assess whether respiratory impedance is feasible during hyperacute stroke management, and to determine the effect of volume status on the hemodynamic response to respiratory impedance.

  • Abstract WP322: Inhaled Nitric Oxide Augments Cerebral Blood Flow in Healthy Subjects

    by Christopher G Favilla, Rodrigo M Forti, Ahmad Zamzam, John A Detre, Michael T Mullen, Arjun G Yodh, Scott E Kasner, David R Busch, Wesley B Baker, Steven R Messe

    Introduction: Optimizing cerebral blood flow (CBF) is a cornerstone of clinical management for a number of neurologic disease states, most notably acute ischemic stroke. Transdermal nitric oxide donors are being investigated for acute stroke, though the effect of inhaled nitric oxide (iNO) on CBF remains largely unknown. Here we aim to quantify the cerebral hemodynamic response to iNO in healthy volunteers. Methods: Cerebral perfusion was measured during three doses of iNO (5ppm, 10ppm, and 20ppm) using the iNOMAX system (Mallinckrodt Pharmaceuticals) in 20 healthy volunteers. Continuous measurements of microvascular CBF were made with diffuse correlation spectroscopy (DCS), while middle cerebral artery mean flow velocity (MFV) was measured with transcranial Doppler. Cardiopulmonary status and nitric oxide toxicity (i.e. NO 2 ) were continuously monitored for safety. Results: Overall, iNO was safe and well tolerated. All subjects completed the protocol in its entirety. All 3 doses of iNO resulted in a small but statistically significant increase in microvascular CBF as compared to baseline (figure). No significant changes in MFV were identified (figure). During administration of iNO, there was no detrimental effect on blood pressure, nor was there any significant accumulation of toxic metabolites. Conclusions: iNO was safe and produced a small but significant increase in microvascular CBF in healthy volunteers. Future studies are warranted to determine the optimal dose of iNO and to explore the effect in acute ischemic stroke patients.

  • Open Access

    Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample

    by Amelia K. Boehme, Brendan G. Carr, Scott Eric Kasner, Karen C. Albright, Michael J. Kallan, Mitchell S. V. Elkind, Charles C. Branas, Michael T. Mullen

    Background and Purpose: Sex and race disparities in recombinant tissue plasminogen activator (rt-PA) use have been reported. We sought to explore sex and race differences in the utilization of rt-PA at primary stroke centers (PSCs) compared to non-PSCs across the US. Methods: Data from the National (Nationwide) Inpatient Sample (NIS) 2004-2010 was utilized to assess sex differences in treatment for ischemic stroke in PSCs compared to non-PSCs. Results: There were 304,152 hospitalizations with a primary diagnosis of ischemic stroke between 2004 and 2010 in the analysis: 75,160 (24.7%) patients were evaluated at a PSC. A little over half of the patients evaluated at PSCs were female (53.8%). A lower proportion of women than men received rt-PA at both PSCs (6.8% vs. 7.5%, p<0.001) and non-PSCs (2.3% vs. 2.8%, p<0.001). After adjustment for potential confounders the odds of being treated with rt-PA remained lower for women regardless of presentation to a PSC (OR 0.87, 95% CI (0.81-0.94) or non-PSC (OR 0.88, 95% CI 0.82-0.94). After stratifying by sex and race, the lowest absolute treatment rates were observed in black women (4.4% at PSC, 1.9% at non-PSC). The odds of treatment, relative to white men, was however lowest for white women (PSC OR=0.85, 95% CI 0.78-0.93; non-PSC OR=0.80, 95% CI 0.75-0.85). In the multivariable model, sex did not modify the effect of PSC certification on rt-PA utilization (p-value for interaction =0.58). Conclusion: Women are less likely to receive rt-PA than men at both PSCs and non-PSCs. Absolute treatment rates are lowest in black women, although the relative difference in men and women was greatest for white women.


  • Open Access

    Accuracy of Emergency Medical Services Dispatcher and Crew Diagnosis of Stroke in Clinical Practice

    by Judy Jia, Roger Band, Michael E. Abboud, William Pajerowski, Michelle Guo, Guy David, C. Crawford Mechem, Steven R. Messé, Brendan G. Carr, Michael T. Mullen

    Background: Accurate recognition of stroke symptoms by Emergency Medical Services (EMS) is necessary for timely care of acute stroke patients. We assessed the accuracy of stroke diagnosis by EMS in clinical practice in a major US city. Methods and Results: Philadelphia Fire Department data were merged with data from a single comprehensive stroke center to identify patients diagnosed with stroke or TIA from 9/2009 to 10/2012. Sensitivity and positive predictive value (PPV) were calculated. Multivariable logistic regression identified variables associated with correct EMS diagnosis. There were 709 total cases, with 400 having a discharge diagnosis of stroke or TIA. EMS crew sensitivity was 57.5% and PPV was 69.1%. EMS crew identified 80.2% of strokes with NIHSS ≥ 5 and symptom duration 270min (OR 0.41, 95% CI 0.25-0.68). EMS dispatchers identified 90 stroke cases that the EMS crew missed. EMS dispatcher or crew identified stroke with sensitivity of 80% and PPV of 50.9%, and EMS dispatcher or crew identified 90.5% of patients with NIHSS ≥ 5 and symptom duration<6 hours. Conclusions: Prehospital diagnosis of stroke has limited sensitivity, resulting in a high proportion of missed stroke cases. Dispatchers identified many strokes that EMS crews did not. Incorporating EMS dispatcher impression into regional protocols may maximize the effectiveness of hospital destination selection and pre-notification.


  • Endovascular thrombectomy

    by Michael T. Mullen, Seemant Chaturvedi


  • Top Cited Papers

    Disparities in access to trauma care in the United States: A population-based analysis

    by Brendan G. Carr, Ariel J. Bowman, Catherine S. Wolff, Michael T. Mullen, Daniel N. Holena, Charles C. Branas, Douglas J. Wiebe


  • Open Access

    TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage

    by Roslyn A. Taylor, Che-Feng Chang, Brittany A. Goods, Matthew D. Hammond, Brian Mac Grory, Youxi Ai, Arthur F. Steinschneider, Stephen C. Renfroe, Michael H. Askenase, Louise D. McCullough, et al.

    Intracerebral hemorrhage (ICH) is a devastating form of stroke that results from the rupture of a blood vessel in the brain, leading to a mass of blood within the brain parenchyma. The injury causes a rapid inflammatory reaction that includes activation of the tissue-resident microglia and recruitment of blood-derived macrophages and other leukocytes. In this work, we investigated the specific responses of microglia following ICH with the aim of identifying pathways that may aid in recovery after brain injury. We used longitudinal transcriptional profiling of microglia in a murine model to determine the phenotype of microglia during the acute and resolution phases of ICH in vivo and found increases in TGF-β1 pathway activation during the resolution phase. We then confirmed that TGF-β1 treatment modulated inflammatory profiles of microglia in vitro. Moreover, TGF-β1 treatment following ICH decreased microglial Il6 gene expression in vivo and improved functional outcomes in the murine model. Finally, we observed that patients with early increases in plasma TGF-β1 concentrations had better outcomes 90 days after ICH, confirming the role of TGF-β1 in functional recovery from ICH. Taken together, our data show that TGF-β1 modulates microglia-mediated neuroinflammation after ICH and promotes functional recovery, suggesting that TGF-β1 may be a therapeutic target for acute brain injury.